Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
2.840
+0.290 (11.37%)
At close: Jun 6, 2025, 4:00 PM
2.870
+0.030 (1.06%)
After-hours: Jun 6, 2025, 7:59 PM EDT
Sana Biotechnology Market Cap
Sana Biotechnology has a market cap or net worth of $640.58 million as of June 6, 2025. Its market cap has decreased by -66.49% in one year.
Market Cap
640.58M
Enterprise Value
627.19M
1-Year Change
-66.49%
Ranking
Category
Stock Price
$2.84
Market Cap Chart
Since the IPO on February 4, 2021, Sana Biotechnology's market cap has decreased from $1.33B to $640.58M, a decrease of -51.66%. That is a compound annual growth rate of -15.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2025 | 575.17M | 58.04% |
| Dec 31, 2024 | 363.93M | -54.75% |
| Dec 29, 2023 | 804.30M | 7.21% |
| Dec 30, 2022 | 750.19M | -73.52% |
| Dec 31, 2021 | 2.83B | 113.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 687.52B |
| Johnson & Johnson | 368.66B |
| AbbVie | 330.92B |
| Novo Nordisk | 324.15B |
| UnitedHealth Group | 272.49B |
| Abbott Laboratories | 231.33B |
| Novartis AG | 229.87B |
| AstraZeneca | 226.47B |